Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: An updated meta-analysis

Georg Griesinger*, Efstratios Michaelis Kolibianakis, Christos Venetis, Klaus Diedrich, Basil Tarlatzis

*Corresponding author for this work
63 Citations (Scopus)

Abstract

Ongoing pregnancy rate (PR) per randomized woman was found to be significantly lower in patients with oral contraceptive (OC) pill pretreatment (relative risk: 0.80, 95% confidence interval [CI]: 0.66-0.97; rate difference: -5%, 95% CI: -10% to -1%; fixed effects model) after pooling data from six randomized controlled trials encompassing 1,343 patients. Duration of stimulation (weighted mean difference [WMD]: +1.33 days, 95% CI: +0.61-2.05) and gonadotropin consumption (WMD: +360 IUs, 95% CI: +158-563) were significantly increased after OC pretreatment, but there was no statistically significant gain in the number of cumulus-oocyte complexes (WMD: +0.6 cumulus-oocyte complexes, 95% CI: -0.08-1.25).

Original languageEnglish
JournalFertility and Sterility
Volume94
Issue number6
Pages (from-to)2382-2384
Number of pages3
ISSN0015-0282
DOIs
Publication statusPublished - 01.11.2010

Fingerprint

Dive into the research topics of 'Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: An updated meta-analysis'. Together they form a unique fingerprint.

Cite this